首页> 外文期刊>Experimental Neurology >Amyloid-beta peptide affects viability but not differentiation of embryonic and adult rat hippocampal progenitor cells.
【24h】

Amyloid-beta peptide affects viability but not differentiation of embryonic and adult rat hippocampal progenitor cells.

机译:β淀粉样蛋白肽影响存活力,但不影响胚胎和成年大鼠海马祖细胞的分化。

获取原文
获取原文并翻译 | 示例
           

摘要

The neurological deficits that are characteristic of Alzheimer's Disease (AD) are ultimately a result of neuronal loss in distinct anatomical regions of the brain. This neuronal loss is thought to be due, in large part to the presence of the neurotoxic beta-amyloid (Abeta) deposits, that are characteristic of the AD brain. Transplantation therapy, in which neural stem cells (NSCs) or neural progenitor cells (NPCs) are introduced into damaged regions of the brain and induced to differentiate into replacement neurons, has been proposed as a possible therapeutic approach to treat AD. However, in the AD brain Abeta plaques, which remain in the area of neuronal degeneration, may affect the viability or differentiation potential of transplanted NSCs. Currently there is contradictory evidence concerning the effect of Abeta on NSCs. To further investigate the effect of Abeta on NSCs, we compared the mitochondrial function, proliferation and cellular differentiation of two populations of hippocampal NSCs (embryonic and adult derived) after Abeta exposure. Our results highlight the heterogeneity between different populations of NSCs even when derived from the same brain region. Our data also demonstrate that while mitochondrial function of NSCs is affected by Abeta, their proliferation and differentiation are not significantly influenced. Considered with previous studies, our results suggest that while NSCs do respond to the presence of Abeta, proliferation and differentiation of certain populations are not affected. Further study of the differences between susceptible vs. resistant populations of NSCs may provide crucial clues for the development of effective therapies to combat AD.
机译:阿尔茨海默氏病(AD)所特有的神经系统缺陷最终是大脑不同解剖区域神经元丢失的结果。人们认为,这种神经元丢失很大程度上是由于存在AD大脑的神经毒性β-淀粉样蛋白(Abeta)沉积物所致。已经提出了将神经干细胞(NSC)或神经祖细胞(NPC)引入大脑受损区域并被诱导分化为替代神经元的移植疗法,作为治疗AD的一种可能的治疗方法。但是,在AD脑中,残留在神经元变性区域的Abeta斑块可能会影响已移植NSC的活力或分化潜能。目前,关于Abeta对NSC的作用存在矛盾的证据。为了进一步研究Abeta对NSC的影响,我们比较了暴露于Abeta后两个海马NSC(胚胎和成年衍生)群体的线粒体功能,增殖和细胞分化。我们的结果强调了即使来自同一大脑区域,NSCs的不同种群之间的异质性。我们的数据还表明,虽然NSC的线粒体功能受到Abeta的影响,但它们的增殖和分化并未受到显着影响。考虑到先前的研究,我们的结果表明,尽管NSC确实对Abeta的存在做出了反应,但某些人群的增殖和分化并未受到影响。进一步研究NSCs易感人群与耐药性人群之间的差异可能为开发有效的抗AD疗法提供重要线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号